Prospective multicenter cohort study on the efficacy and safety of benralizumab in the treatment of severe asthma
Not Applicable
Recruiting
- Conditions
- Bronchial Asthma
- Registration Number
- JPRN-UMIN000033615
- Lead Sponsor
- Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with intention to refuse to participate in this research. 2.Patients with a history of hypersensitivity to this drug and the ingredients of this drug. 3. Patients under 20 years old. 4. Patients who may be pregnant. 5. Patients with breastfeeding 6. Patients deemed ineligible by the attending physicians for various reasons.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Spirometry
- Secondary Outcome Measures
Name Time Method Astma Control Test(ACT), Asthma Control Questionnaire(ACQ), Asthma Quality of Life Questionnaire(AQLQ), FeNO, Objective opinion, Sputum eosinophil counts, Chest X-ray, Chest CT, Respiratory resistance test, Oral corticosteroid dose, Absence of unexpected visit and hospitalization due to asthma exacerbation, Clinical examination, Sinus CT, Safety